Joseph V. Osti, Jr., DPM FACFAS Podiatrist - Foot & Ankle Surgery Medicare: Not Enrolled in Medicare Practice Location: 1170 Niles Cortland Rd, Suite 1, Niles, OH 44446 Phone: 330-544-4141 Fax: 330-544-4134 |
Eugene D Podolsky, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 720 Youngstown Warren Rd, Niles, OH 44446 Phone: 330-652-0535 Fax: 330-652-0536 |
Thomas Groner, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 720 Youngstown Warren Rd, Niles, OH 44446 Phone: 330-652-0535 Fax: 330-652-0536 |
Ohio Podiatric Physicians And Surgeons Group, Llc Podiatrist - Primary Podiatric Medicine Medicare: Not Enrolled in Medicare Practice Location: 720 Youngstown Warren Rd, Niles, OH 44446 Phone: 330-652-0535 Fax: 330-652-0536 |
Associates In Foot & Ankle Care Inc Podiatrist - Foot & Ankle Surgery Medicare: Not Enrolled in Medicare Practice Location: 1170 Niles Cortland Rd, Suite 1, Niles, OH 44446 Phone: 330-544-4141 Fax: 330-544-4134 |
Dr. Ramy Fahim, DPM Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 720 Youngstown Warren Rd, Niles, OH 44446 Phone: 330-652-0535 Fax: 330-652-0536 |
Associates In Foot & Ankle Care Inc Podiatrist - Foot & Ankle Surgery Medicare: Medicare Enrolled Practice Location: 1250 Youngstown Warren Rd Unit 1a, Niles, OH 44446 Phone: 330-544-4141 Fax: 330-544-4134 |
Ankle And Foot Care Centers Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 720 Youngstown Warren Rd, Niles, OH 44446 Phone: 330-652-0535 Fax: 330-652-0536 |
News Archive
What if a smartphone app could help you avoid relapsing back to smoking even before you knew you were at risk? A researcher from the Oklahoma Tobacco Research Center at the Stephenson Cancer Center is developing smartphone-based technology to help people receive real-time tobacco cessation treatment when they are most at risk.
Mayo Clinic researchers have designed a new strategy in the promising field of cancer vaccine research that's proven to be successful in boosting T cells - the immune builders akin to a super defense force against cancer cells.
NeoPharm, Inc. a biopharmaceutical company dedicated to the research, development and commercialization of new and innovative therapeutic applications of drugs for cancer and other diseases, today announced it has entered into a merger agreement with Insys Therapeutics, a Phoenix-based drug development company focused on pain and oncology.
The last patient in the EU Diamyd Phase III clinical study has completed the 15-month visit, meaning that all patients in this study have completed the main 15 month study period in this trial. This important achievement in the Diamyd® Phase III program will now be followed by an intense period where the data will be compiled from the more than 60 clinics throughout Europe and from the central laboratory.
› Verified 7 days ago